Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trial
Conclusion: Mastiha inhibited an increase in plasma free AAs seen in patients with quiescent IBD. Since change of AAs is considered an early prognostic marker of disease activity, this indicates a potential role of Mastiha in remission maintenance.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Chia | Cholesterol | Clinical Trials | Diets | Drugs & Pharmacology | Inflammatory Bowel Disease | Nutrition | Statistics | Study